TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29262471

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D level in ASD children
Number of subjects: 87

Group type: COMPARATOR
Intervention: Normal vitamin D levels
Number of subjects: 87

Group type: COMPARATOR
Intervention: Insufficient vitamin D levels
Number of subjects: 87

Group type: COMPARATOR
Intervention: Deficient vitamin D levels
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Serum vitamin D level
Number of subjects: 87
Study: 25562462

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone plus counseling
Number of subjects: 360
Study: 25125053

Group type: EXPERIMENTAL
Intervention: Ketorolac + Acetazolamide (250 mg acetazolamide before anesthetic induction and 30 mg ketorolac in the immediate postoperative period)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ketorolac (30 mg in the immediate postoperative period)
Number of subjects: 62
Study: 19966102

Group type: EXPERIMENTAL
Intervention: Matrix-associated autologous chondrocyte implantation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Original periosteal flap technique
Number of subjects: 21
Study: 19057629

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections of local anesthetic (lidocaine 0.5%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Caudal epidural injections with 0.5% lidocaine 9 mL mixed with 1 mL of steroid
Number of subjects: 40
Study: 16849364

Group type: EXPERIMENTAL
Intervention: Baby in mother's bed with cot-side
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Baby in side-car crib attached to mother's bed
Number of subjects: 64

Group type: COMPARATOR
Intervention: Baby in stand-alone cot adjacent to mother's bed
Number of subjects: 64
Study: 12499349

Group type: EXPERIMENTAL
Intervention: Glutamine-enriched nutrition
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Glutamine-enriched diet in rats
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control diet in rats
Number of subjects: 29
Study: 10744893

Group type: EXPERIMENTAL
Intervention: Silent teacher modeling
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Enthusiastic teacher modeling
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Enthusiastic teacher modeling with competing peer model
Number of subjects: 58
Study: 8741094

Group type: EXPERIMENTAL
Intervention: 80 mg ketoprofen lysine salt
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 2067317

Group type: EXPERIMENTAL
Intervention: Cyclandelate (1200 mg, single oral dosage)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 6618436

Group type: EXPERIMENTAL
Intervention: Prednisolone therapy
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Combination therapy (azathioprine and prednisolone)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Azathioprine therapy
Number of subjects: 204

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 204
Study: 31660654

Group type: EXPERIMENTAL
Intervention: PARK2 mutation (c.155delA)
Number of subjects: 7849

Group type: EXPERIMENTAL
Intervention: SNCA, LRRK2, KANSL1/MAPT, HLA-DQB1
Number of subjects: 7849

Group type: COMPARATOR
Intervention: Known loci
Number of subjects: 7849

Group type: COMPARATOR
Intervention: 28 known genes/loci
Number of subjects: 7849
Study: 30110086

Group type: EXPERIMENTAL
Intervention: Reciproc R25/.08 + Clearsonic tip
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Clearsonic tip + Reciproc R25/.08
Number of subjects: 45

Group type: COMPARATOR
Intervention: Reciproc R25/.08
Number of subjects: 45
Study: 28232467

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural writing therapy (IB-CBWT) for PTSD, guided by a therapist, comprising two written assignments per week over a 5-week period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list (WL) control group receiving treatment after a waiting period of 5 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural writing therapy (IB-CBWT) for PTSD.
Number of subjects: 0
Study: 25604313

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg (intensive)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg (conventional)
Number of subjects: 96
Study: 23086679

Group type: EXPERIMENTAL
Intervention: Cutanplast
Number of subjects: 100

Group type: COMPARATOR
Intervention: Merocel
Number of subjects: 100
Study: 21044517

Group type: EXPERIMENTAL
Intervention: Teaching-Learning contexts
Number of subjects: 2020

Group type: EXPERIMENTAL
Intervention: Causal model of academic performance
Number of subjects: 2020
Study: 18173612

Group type: EXPERIMENTAL
Intervention: Lidocaine 7%-tetracaine 7% peel applied for 30, 60, or 90 min over a 50-, 100-, or 200-cm² area
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lidocaine 7%-tetracaine 7% peel
Number of subjects: 36
Study: 16314879

Group type: EXPERIMENTAL
Intervention: High-carbohydrate (CHO) drinks (2.1 MJ/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-fat (FAT) drinks (2.1 MJ/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-protein (PRO) drinks (2.1 MJ/day)
Number of subjects: 12
Study: 14676650

Group type: EXPERIMENTAL
Intervention: Mild hypothermia (intracranial temperature, 34 degrees C) for 48 hours followed by rewarming at a rate of 1 degrees C per day for 3 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Normothermia (intracranial temperature, 37 degrees C) for 5 days
Number of subjects: 17
Study: 11967819

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study: 8991338

Group type: EXPERIMENTAL
Intervention: Experimental nurses using the ACCS and MAFS for pain ratings
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control nurses using customary method of assessment
Number of subjects: 124
Study: 8431125

Group type: EXPERIMENTAL
Intervention: Neodymium:YAG laser dissection at 15 W continuous beam
Number of subjects: 100

Group type: COMPARATOR
Intervention: Electrosurgical dissection with 'L' hook and spatula electrodes at 25 W coagulation current
Number of subjects: 100
Study: 3429696

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol 60 mg (LA 60 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional propranolol 20 mg tid
Number of subjects: 34
Study: 30322091

Group type: EXPERIMENTAL
Intervention: Moringa oleifera leaf powder (20 g)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control meal (CNT)
Number of subjects: 27
Study: 27371106

Group type: EXPERIMENTAL
Intervention: Goal-setting telephone follow-up intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 23452836

Group type: EXPERIMENTAL
Intervention: Intrathecal injection(s) of autologous adherent bone marrow cells combined with physical therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Physical therapy alone
Number of subjects: 70
Study: 24509458

Group type: EXPERIMENTAL
Intervention: Doppler-guided transanal hemorrhoid dearterialization with mucopexy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hemorrhoidectomy
Number of subjects: 50
Study: 22303910

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine 300/10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine 300/5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aliskiren 300 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine SPCs (both dosages combined)
Number of subjects: 0
Study: 21195988

Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 66

Group type: COMPARATOR
Intervention: Ketorolac
Number of subjects: 66
Study: 17184371

Group type: EXPERIMENTAL
Intervention: Bladder training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voiding programmes (prompted voiding, habit retraining, timed voiding)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 16123483

Group type: EXPERIMENTAL
Intervention: Transplant group (G-CSF-mobilized PBMNCs)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 11879208

Group type: EXPERIMENTAL
Intervention: 0.4 MAC sevoflurane with remifentanil
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 0.8 MAC sevoflurane with remifentanil
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 14 microg x kg(‐1) x h(‐1) remifentanil and 1.24% end‐tidal sevoflurane
Number of subjects: 3
Study: 10630837

Group type: EXPERIMENTAL
Intervention: Amphetamines and amphetamine derivatives (mazindol, dextroamphetamine, methylphenidate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 8866625

Group type: EXPERIMENTAL
Intervention: Nebulised fenoterol (2 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol (2 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline control (0.45% saline)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Fenoterol and salbutamol
Number of subjects: 13
Study: 1610589

Group type: EXPERIMENTAL
Intervention: 5-day preoperative treatment with oral administration of 60 mg diltiazem 3 times daily, 10 mg diltiazem intravenously as a bolus dose before the beginning of the cardiopulmonary bypass, and 5 mg diltiazem intravenously 10 min before removal of aortic clamp
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5-day preoperative treatment with oral administration of 60 mg diltiazem 3 times daily
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 10 mg diltiazem intravenously as a bolus dose before the beginning of CPB and 5 mg 10 min before removal of the aortic clamp
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 15 mg diltiazem in 1000 ml cardioplegic solution, given as additive
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group not receiving diltiazem
Number of subjects: 90
Study: 6142775

Group type: EXPERIMENTAL
Intervention: Prenalterol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31640613

Group type: EXPERIMENTAL
Intervention: Low-Ratio version of the CBM program (Arm 1)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: High-Ratio 'active' CBM program (Arm 2)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: High-Ratio CBM program with adherence promotion (Arm 3)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 498
Study: 29754673

Group type: EXPERIMENTAL
Intervention: Digoxin therapy
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 2331
Study: 27401339

Group type: EXPERIMENTAL
Intervention: Hartmann's procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intersphincteric abdominoperineal excision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 25269598

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g every 24 hours intravenously for 4 days in addition to standard stroke-unit care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard stroke-unit care without preventive antibiotic therapy
Number of subjects: 0
Study: 21664059

Group type: EXPERIMENTAL
Intervention: Lyman-Kutcher-Burman (LKB) model
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Relative Seriality (RS) model
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Logistic model
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: LKB model
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Baseline toxicity score
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: All models
Number of subjects: 512
Study: 20124169

Group type: EXPERIMENTAL
Intervention: High-dose radiation therapy (79.2 GyE)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Conventional-dose radiation therapy (70.2 GyE)
Number of subjects: 393
Study: 17353238

Group type: EXPERIMENTAL
Intervention: Tigecycline 100 mg loading dose/50 mg every 12 h
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Tigecycline 50 mg loading dose/25 mg every 12 h
Number of subjects: 35

Group type: COMPARATOR
Intervention: All pathogens combined
Number of subjects: 35
Study: 16302004

Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Excessive sodium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low potassium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical inactivity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low intake of fish oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low calcium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low magnesium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Excessive coffee consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Excessive alcohol intake
Number of subjects: 0
Study: 11886356

Group type: EXPERIMENTAL
Intervention: IVMP 2 g/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IVMP 1 g/day
Number of subjects: 24
Study: 9817153

Group type: EXPERIMENTAL
Intervention: Cold air exposure (‐23 degrees C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal indoor air exposure (+22 degrees C)
Number of subjects: 8
Study: 7843440

Group type: EXPERIMENTAL
Intervention: Subdermal levonorgestrel‐releasing implant
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intrauterine device (IUD) releasing levonorgestrel
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 1334803

Group type: EXPERIMENTAL
Intervention: Prinivil 10 to 40 mg once daily
Number of subjects: 135

Group type: COMPARATOR
Intervention: Procardia XL 30 to 120 mg once daily
Number of subjects: 135
Study: 6502311

Group type: EXPERIMENTAL
Intervention: Bovine superoxide dismutase (0.25 mg/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 45
Study: 30859515

Group type: EXPERIMENTAL
Intervention: Baseline screening for diabetes and prediabetes
Number of subjects: 196
Study: 29935150

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy screening (intervention group)
Number of subjects: 4
Study: 27113085

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 452
Study: 25558265

Group type: EXPERIMENTAL
Intervention: Childbirth training workshop
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 180
Study: 22779215

Group type: EXPERIMENTAL
Intervention: New dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm sodium monofluorophosphate (MFP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available dentifrice containing 1000 ppm sodium monofluorophosphate (MFP)
Number of subjects: 0
Study: 20869710

Group type: EXPERIMENTAL
Intervention: EPBD for 5 minutes (n = 84)
Number of subjects: 170

Group type: COMPARATOR
Intervention: EPBD for 1 minute (n = 86)
Number of subjects: 170
Study: 17892635

Group type: EXPERIMENTAL
Intervention: Transdermal patch containing rivastigmine (Exelon)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral administration of AD therapies
Number of subjects: 0
Study: 16359213

Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT)
Number of subjects: 220
Study: 12043315

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (24 patients, 15 men and 9 women, average age 42.3 years)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Imipramine (24 patients, 18 men and 6 women, average age 43.2 years)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Tramadol (22 patients, 18 men and 4 women, average age 42.9 years)
Number of subjects: 70
Study: 10543267

Group type: EXPERIMENTAL
Intervention: 800 mg albendazole daily in three cycles of 6 weeks with 2 weeks between cycles
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8544113

Group type: EXPERIMENTAL
Intervention: Imagery condition
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Presence condition
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 1977780

Group type: EXPERIMENTAL
Intervention: Terfenadine 60 mg twice daily
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 897573

Group type: EXPERIMENTAL
Intervention: 1000 mg vitamin C daily (pilot study)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: 1000 mg vitamin C daily (main study)
Number of subjects: 814

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 814
Study: 31013363

Group type: EXPERIMENTAL
Intervention: Aramchol 600 mg daily for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Aramchol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Aramchol and Placebo
Number of subjects: 50
Study: 28524039

Group type: EXPERIMENTAL
Intervention: Gubiao Pixie prescription (Radix Astragali 30 g, Bran fried Rhizoma Atracylodis 20 g, Raidix Saposhnikoviae 12 g, Radix Scutellariae 10 g, Fructus Tsaoko 6 g), taken in warm water 300 mL, twice a day after meals for 10 days.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment without special intervention (Control group).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gubiao Pixie prescription (experimental group).
Number of subjects: 100
Study: 25732251

Group type: EXPERIMENTAL
Intervention: Nap (∼90min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (watched DVDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (Nap and Control)
Number of subjects: 0
Study: 23538158

Group type: EXPERIMENTAL
Intervention: Early infarct-related artery (IRA) patency (TIMI 2 or 3 flow)
Number of subjects: 3093

Group type: COMPARATOR
Intervention: No early IRA patency (TIMI 0 or 1 flow)
Number of subjects: 3093
Study: 22045968

Group type: EXPERIMENTAL
Intervention: OMT plus PCI
Number of subjects: 489

Group type: COMPARATOR
Intervention: OMT only
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 489
Study: 19705035

Group type: EXPERIMENTAL
Intervention: Neurexan
Number of subjects: 826

Group type: COMPARATOR
Intervention: Valerian
Number of subjects: 826
Study: 17079851

Group type: EXPERIMENTAL
Intervention: Activated vitamin D3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain vitamin D
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bisphosphonate
Number of subjects: 0
Study: 15307012

Group type: EXPERIMENTAL
Intervention: Triple-drug therapy (indinavir + zidovudine or stavudine + lamivudine)
Number of subjects: 1156

Group type: COMPARATOR
Intervention: Dual-drug therapy (zidovudine or stavudine + lamivudine)
Number of subjects: 1156
Study: 11397621

Group type: EXPERIMENTAL
Intervention: Continuous infusion of ceftazidime (3 g/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intermittent infusion of ceftazidime (2 g every 8 h)
Number of subjects: 35
Study: 9425681

Group type: EXPERIMENTAL
Intervention: Word frequency effects on lexical decision task (LDT) at 75% accuracy level.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mental lexica of participants with very-low-frequency words.
Number of subjects: 0
Study: 7506324

Group type: EXPERIMENTAL
Intervention: Bimakalim (0.25-1 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3329967

Group type: EXPERIMENTAL
Intervention: Fioricet
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Acetaminophen with codeine
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 29533674

Group type: EXPERIMENTAL
Intervention: Suture-bridge technique augmented with 3D collagen
Number of subjects: 112

Group type: COMPARATOR
Intervention: Suture-bridge technique
Number of subjects: 112
Study: 27441910

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) consisting of 8 weekly cycles of cetuximab, carboplatin, and paclitaxel followed by CRT
Number of subjects: 118

Group type: COMPARATOR
Intervention: Chemoradiation (CRT)
Number of subjects: 118
Study: 24681859

Group type: EXPERIMENTAL
Intervention: Congenital aural atresia (CAA)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Sensorineural hearing loss (SNHL)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 23587875

Group type: EXPERIMENTAL
Intervention: ropivacaine 0.5% and dexamethasone 10 mg (RD)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: ropivacaine 0.5% with i.v. dexamethasone 10 mg (RDiv)
Number of subjects: 150

Group type: COMPARATOR
Intervention: ropivacaine 0.5% (R)
Number of subjects: 150
Study: 20645666

Group type: EXPERIMENTAL
Intervention: Pharmacy utilization algorithm
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pharmacy utilization
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Algorithm identification
Number of subjects: 100
Study: 19278082

Group type: EXPERIMENTAL
Intervention: Colgate® Total® dentifrice
Number of subjects: 28

Group type: COMPARATOR
Intervention: Colgate® Cavity Protection dentifrice
Number of subjects: 28
Study: 15948697

Group type: EXPERIMENTAL
Intervention: 0.5% cimetidine rinse
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 37
Study: 12891954

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous terbutaline infusion (SQ group)
Number of subjects: 558

Group type: COMPARATOR
Intervention: Oral tocolytics (PO group)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Overall costs for SQ group
Number of subjects: 558
Study: 10999085

Group type: EXPERIMENTAL
Intervention: Group A (0,1,2 schedule)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Group B (0,1,2,6 schedule)
Number of subjects: 117